- Home
- ARMP vs ONEG Comparison
ARMP vs ONEG Comparison
Compare ARMP & ONEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- ONEG
- Stock Information
- Founded
- ARMP N/A
- ONEG 2021
- Country
- ARMP United States
- ONEG Hong Kong
- Employees
- ARMP N/A
- ONEG N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- ONEG Homebuilding
- Sector
- ARMP Health Care
- ONEG Consumer Discretionary
- Exchange
- ARMP Nasdaq
- ONEG Nasdaq
- Market Cap
- ARMP 52.1M
- ONEG 43.3M
- IPO Year
- ARMP N/A
- ONEG 2024
- Fundamental
- Price
- ARMP $2.22
- ONEG $7.20
- Analyst Decision
- ARMP Strong Buy
- ONEG
- Analyst Count
- ARMP 1
- ONEG 0
- Target Price
- ARMP $9.00
- ONEG N/A
- AVG Volume (30 Days)
- ARMP 18.4K
- ONEG 582.9K
- Earning Date
- ARMP 08-12-2025
- ONEG 01-01-0001
- Dividend Yield
- ARMP N/A
- ONEG N/A
- EPS Growth
- ARMP N/A
- ONEG N/A
- EPS
- ARMP N/A
- ONEG 0.12
- Revenue
- ARMP $4,699,000.00
- ONEG $60,903,000.00
- Revenue This Year
- ARMP $8.43
- ONEG N/A
- Revenue Next Year
- ARMP N/A
- ONEG N/A
- P/E Ratio
- ARMP N/A
- ONEG $52.88
- Revenue Growth
- ARMP 14.24
- ONEG 16.46
- 52 Week Low
- ARMP $0.90
- ONEG $1.48
- 52 Week High
- ARMP $3.42
- ONEG $10.80
- Technical
- Relative Strength Index (RSI)
- ARMP 63.56
- ONEG N/A
- Support Level
- ARMP $1.93
- ONEG N/A
- Resistance Level
- ARMP $2.24
- ONEG N/A
- Average True Range (ATR)
- ARMP 0.16
- ONEG 0.00
- MACD
- ARMP 0.03
- ONEG 0.00
- Stochastic Oscillator
- ARMP 104.55
- ONEG 0.00
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. It is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.